Report #2866721

Received Oct 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Fungal infection

Symptom narrative

face has what looks fungal; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fungal infection in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fungal infection (Verbatim: face has what looks fungal). The outcome of the fungal infection was not reported. It was unknown if the reporter considered the fungal infection to be related to Shingrix. It was unknown if the company considered the fungal infection to be related to Shingrix. Additional Information: GSK Receipt Date: 08-OCT-2025 The patient received Shingrix vaccine and the face had looks fungal it washes away with effaclar, but immediately comes back.